Assadiasl Sara, Fatahi Yousef, Zavvar Mahdi, Nicknam Mohammad Hossein
Molecular Immunology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Department of Pharmaceutical Nanotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
Hum Antibodies. 2020;28(4):287-297. doi: 10.3233/HAB-200429.
The newly emerged severe acute respiratory syndrome-related coronavirus-2 (SARS-CoV-2) has recently caused pandemic Coronavirus Disease-2019 (COVID-19). Considering the serious medical, economic and social consequences of this pandemic and the lack of definite medication and vaccine it is necessary to describe natural immune responses to the SARS-CoV-2 in order to exploit them for treating the patients and monitoring the general population. Moreover, detecting the most immunogenic antigens of the virus is fundamental for designing effective vaccines. Antibodies being valuable for diagnostic therapeutic and protective purposes are suitable to be addressed in this context. Herein, we have summarized the findings of serological investigations and the outcomes of neutralizing antibodies administration in COVID-19 patients.
新出现的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)最近引发了新型冠状病毒肺炎(COVID-19)大流行。鉴于此次大流行造成的严重医学、经济和社会后果,以及缺乏确切的药物和疫苗,有必要描述针对SARS-CoV-2的天然免疫反应,以便将其用于治疗患者和监测普通人群。此外,检测该病毒最具免疫原性的抗原是设计有效疫苗的基础。抗体对于诊断、治疗和保护目的具有重要价值,适合在这一背景下进行探讨。在此,我们总结了COVID-19患者血清学调查结果以及中和抗体给药的结果。